240 related articles for article (PubMed ID: 33091800)
1. The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.
Marta GN; Coles C; Kaidar-Person O; Meattini I; Hijal T; Zissiadis Y; Pignol JP; Ramiah D; Ho AY; Cheng SH; Sancho G; Offersen BV; Poortmans P
Crit Rev Oncol Hematol; 2020 Dec; 156():103090. PubMed ID: 33091800
[TBL] [Abstract][Full Text] [Related]
2. Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials.
Marta GN; Riera R; Pacheco RL; Cabrera Martimbianco AL; Meattini I; Kaidar-Person O; Poortmans P
Breast; 2022 Apr; 62():84-92. PubMed ID: 35131647
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
[TBL] [Abstract][Full Text] [Related]
4. Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean.
Marta GN; Moraes FY; de Oliveira Franco RC; de Andrade Carvalho H; Gouveia AG; de Lima Gössling GC; de Jesus RG; Ferraris G; Schuffenegger PM; Bardales GS; Chacón MAP; Murillo R; Sánchez LEM; Gamarra-Cabezas E; Rosa AA; da Silva MF; de Mattos MD; Morais DCR; de Castro DG; Dal Pra A; Amêndola BE; Barros JM; Lara TM; Isa N; de la Mata Moya D; Hidalgo I; Velilla DG; Loayza LEA; Montenegro FG; Sanchez Chacin NO; Werutsky G; Viani GA
Rep Pract Oncol Radiother; 2023; 28(3):340-351. PubMed ID: 37795395
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
[TBL] [Abstract][Full Text] [Related]
7. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
[TBL] [Abstract][Full Text] [Related]
8. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH; Tree AC; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Chan A; Dayes IS; Henderson D; Brown S; Cruickshank C; Burnett S; Duffton A; Griffin C; Hinder V; Morrison K; Naismith O; Hall E; van As N;
Lancet Oncol; 2019 Nov; 20(11):1531-1543. PubMed ID: 31540791
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated radiation treatment in the management of breast cancer.
Gupta A; Ohri N; Haffty BG
Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionated and hyper-hypofractionated radiation therapy in postoperative breast cancer treatment.
Fang M; Marta GN
Rev Assoc Med Bras (1992); 2020 Sep; 66(9):1301-1306. PubMed ID: 33027462
[TBL] [Abstract][Full Text] [Related]
13. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
[TBL] [Abstract][Full Text] [Related]
15. Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.
Bruand M; Salleron J; Guihard S; Crety CM; Liem X; Pasquier D; Lamrani-Ghaouti A; Charra-Brunaud C; Peiffert D; Clavier JB; Desandes E; Faivre JC
BMC Cancer; 2022 Dec; 22(1):1318. PubMed ID: 36526987
[TBL] [Abstract][Full Text] [Related]
16. Abbreviated course of radiotherapy (RT) for breast cancer.
Schoenfeld JD; Harris JR
Breast; 2011 Oct; 20 Suppl 3():S116-27. PubMed ID: 22015277
[TBL] [Abstract][Full Text] [Related]
17. Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer.
Trone JC; Ollier E; Chapelle C; Mismetti P; Cucherat M; Magné N; Zuffrey PJ; Laporte S
Sci Rep; 2020 Sep; 10(1):15415. PubMed ID: 32963332
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated Whole-Breast Irradiation in Women Less Than 50 Years Old Treated on 4 Prospective Protocols.
Shaikh F; Chew J; Hochman T; Purswani J; Maisonet O; Peat E; Huppert N; Cooper BT; Tam M; Goldberg JD; Perez CA; Formenti SC; Gerber NK
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1159-1167. PubMed ID: 29859789
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated versus conventionally fractionated radiotherapy for ductal carcinoma in situ (DCIS) of the breast.
Oar AJ; Boxer MM; Papadatos G; Delaney GP; Phan P; Descallar J; Duggan K; Tran K; Yap ML
J Med Imaging Radiat Oncol; 2016 Jun; 60(3):407-13. PubMed ID: 27258169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
